Most just lately, it's been identified that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds to some big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger https://richardp369spl8.wikigdia.com/user